Merck 8-K 2009
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 25, 2009
Merck & Co., Inc.
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation)
Registrants Telephone Number, Including Area Code (908) 423-1000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
On June 25, 2009, Merck & Co., Inc. (the Company) closed an underwritten public offering of $1,250,000,000 aggregate principal amount of 1.875% Notes due 2011 (the 2011 Notes), $1,000,000,000 aggregate principal amount of 4.000% Notes due 2015 (the 2015 Notes), $1,250,000,000 aggregate principal amount of 5.000% Notes due 2019 (the 2019 Notes) and $750,000,000 aggregate principal amount of 5.850% Notes due 2039 (the 2039 Notes and, together with the 2011 Notes, the 2015 Notes and the 2019 Notes, the Notes) under the Companys Registration Statement on Form S-3 (Registration No. 333-160134).
Copies of the officers certificate for each series of the Notes (including forms of each of the respective Notes attached thereto) pursuant to Section 301 of the indenture governing the Notes are attached hereto as Exhibits 4.1, 4.2, 4.3 and 4.4 and are incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.